← All trials
NCT01484574
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Feb 1, 2014
- Completion date
- Mar 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Stempeutics Research Pvt LtdLead sponsor
- AMRI HospitalOverall official - principal investigator
- Stanley Medical CollegeOverall official - principal investigator
- Madras Medical CollegeOverall official - principal investigator
- Medanta - The MedicityOverall official - principal investigator
- Nightingale HospitalOverall official - principal investigator
- Sri Jayadeva Institute of Cardiovascular Sciences & ResearchOverall official - principal investigator
- Melaka Manipal Medical CollegeOverall official - principal investigator
- Sri Ramachandra Medical College, ChennaiOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- M.S. Ramaiah Medical College, Bangalore, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.